GO:0047316 L-glutamine:phenylpyruvate transaminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0047316 describes the molecular function that catalyzes the reaction 3-phenylpyruvate + L-glutamine = 2-oxoglutaramate + L-phenylalanine, also known as glutamine transaminase K (GTK) activity.
• This activity is widely distributed in mammalian tissues, with particularly high levels in kidney, liver, and brain, where it participates in amino acid metabolism and nitrogen handling [1,2,4].
• GTK is a dual-substrate enzyme that can use both L-glutamine and L-cysteine (or cysteine S-conjugates) as amino donors, linking it to sulfur amino acid metabolism and xenobiotic bioactivation [4,8].
• The enzyme is identical to cytosolic tyrosine transaminase in rat brain and to kynurenine aminotransferase I (KAT I) in some contexts, highlighting its broad substrate specificity [3,7].
• Altered GTK activity has been implicated in neurological conditions such as Alzheimer's disease through kynurenine pathway dysregulation.
• Research on GO:0047316 benefits from CRISPR-based knockout, knock-in, and overexpression models to dissect its role in metabolism and disease.
Description
L-glutamine:phenylpyruvate transaminase activity (GO:0047316) is a molecular function that catalyzes the reversible transfer of an amino group from L-glutamine to 3-phenylpyruvate, yielding 2-oxoglutaramate and L-phenylalanine. This activity is commonly referred to as glutamine transaminase K (GTK) and is part of the broader class of aminotransferases that play central roles in amino acid homeostasis and nitrogen metabolism [4,6]. The enzyme is widely expressed in mammalian tissues, with especially high activity in kidney, liver, and brain, where it contributes to the metabolism of glutamine, phenylalanine, and sulfur-containing amino acids [1,2,4]. Because of its dual substrate specificity, GTK can also act on cysteine S-conjugates and other α-keto acids, linking it to detoxification pathways and the bioactivation of neurotoxicants [4,8]. Researchers study GO:0047316 to understand how cells balance nitrogen, how phenylalanine and glutamine are interconverted, and how perturbations in these processes may contribute to metabolic and neurological disorders [2,5]. The enzyme's identity as cytosolic tyrosine transaminase in rat brain further underscores its importance in neurotransmitter precursor metabolism.
L-glutamine:phenylpyruvate transaminase activity At A Glance
| GO ID | GO:0047316 |
|---|---|
| GO term | L-glutamine:phenylpyruvate transaminase activity |
| Ontology | molecular_function |
| Synonym | glutamine transaminase K activity; glutamine--phenylpyruvate aminotransferase activity; glutamine-phenylpyruvate transaminase activity |
| Major function | Catalyzes the reversible transamination between L-glutamine and 3-phenylpyruvate to form 2-oxoglutaramate and L-phenylalanine |
| Reaction | 3-phenylpyruvate + L-glutamine = 2-oxoglutaramate + L-phenylalanine |
| Cofactor | Pyridoxal 5'-phosphate (PLP) dependent aminotransferase |
| Tissue distribution | High activity in kidney, liver, and brain; also present in other tissues |
| Substrate specificity | Broad; can also use L-cysteine and cysteine S-conjugates as amino donors |
What Is GO:0047316?
GO:0047316 describes the catalytic activity that converts 3-phenylpyruvate and L-glutamine into 2-oxoglutaramate and L-phenylalanine. In other words, it is an aminotransferase that uses L-glutamine as the amino donor and phenylpyruvate as the amino acceptor, producing phenylalanine and 2-oxoglutaramate. This activity is synonymous with glutamine transaminase K (GTK) and glutamine--phenylpyruvate aminotransferase.
Why Is L-glutamine:phenylpyruvate transaminase activity Important in Cell Biology?
GO:0047316 is important because it sits at the intersection of amino acid metabolism, nitrogen disposal, and sulfur amino acid detoxification. The enzyme glutamine transaminase K (GTK) helps maintain cellular levels of phenylalanine and glutamine, and it participates in the kynurenine pathway, which is relevant to neurological function [4,5]. Its ability to transaminate cysteine S-conjugates links it to the bioactivation of nephrotoxic and neurotoxic compounds, making it a subject of toxicological interest [4,8]. Moreover, GTK is identical to cytosolic tyrosine transaminase in rat brain, suggesting roles in neurotransmitter precursor synthesis. Understanding this activity can illuminate mechanisms of metabolic disorders, kidney ammoniagenesis, and neurodegenerative diseases [2,5].
• Maintains amino acid homeostasis by interconverting glutamine and phenylalanine.
• Participates in renal ammoniagenesis through phenylpyruvate-specific transamination.
• Contributes to sulfur amino acid metabolism and detoxification via cysteine S-conjugate transamination [4,8].
• Plays a role in kynurenine metabolism, linking it to neuroactive compound production [5,7].
• Identified as cytosolic tyrosine transaminase in rat brain, implicating it in neurotransmitter precursor supply.
• Involved in the bioactivation of neurotoxicants, with implications for environmental toxicology.
• Potential target for understanding Alzheimer's disease-related metabolic changes.
• Provides a model for studying dual-substrate recognition in aminotransferases.
• Relevant to kidney function and nitrogen handling.
• Enables research on metabolic reprogramming in cancer and other diseases.
What Happens During L-glutamine:phenylpyruvate transaminase activity?
Substrate Binding and Transamination
In simple terms: The enzyme grabs a glutamine and a phenylpyruvate molecule and swaps an amino group between them.
The reaction begins with the binding of L-glutamine and 3-phenylpyruvate to the active site of glutamine transaminase K (GTK). The enzyme uses pyridoxal 5'-phosphate (PLP) as a cofactor to transfer the α-amino group from glutamine to phenylpyruvate, forming 2-oxoglutaramate and L-phenylalanine [4,6]. This ping-pong bi-bi mechanism is characteristic of aminotransferases, where the amino donor first binds and transfers its amino group to PLP, generating a pyridoxamine intermediate, which then donates the amino group to the acceptor keto acid.
Role in Glutamine and Phenylalanine Metabolism
In simple terms: This reaction helps the body manage glutamine and produce phenylalanine, an essential amino acid.
By converting glutamine to 2-oxoglutaramate, GTK contributes to glutamine utilization and nitrogen transport. The simultaneous production of L-phenylalanine from phenylpyruvate means the enzyme can supply phenylalanine when dietary intake is low, although the primary direction in vivo may vary by tissue. In kidney, this activity is linked to ammoniagenesis, as 2-oxoglutaramate can be further metabolized to produce ammonia, which helps regulate acid-base balance.
Cysteine S-Conjugate Transamination and Detoxification
In simple terms: The enzyme can also act on sulfur-containing molecules, helping to process potentially harmful substances.
GTK is identical to cysteine S-conjugate beta-lyase, meaning it can transaminate cysteine S-conjugates to form reactive thiols that may be toxic or serve as signaling molecules [4,8]. This dual activity places GTK in detoxification pathways for xenobiotics and in the metabolism of sulfur amino acids. The enzyme's ability to use L-cystathionine and related compounds further expands its role in sulfur metabolism.
Kynurenine Pathway Connections
In simple terms: This enzyme also helps make brain-active compounds from tryptophan breakdown.
GTK exhibits kynurenine aminotransferase activity, catalyzing the transamination of kynurenine to kynurenic acid, a neuroactive metabolite [5,7]. This links GO:0047316 to the kynurenine pathway, which is implicated in neuroprotection and neurodegeneration. In Alzheimer's disease, altered kynurenine metabolism has been observed, suggesting a potential role for GTK in disease pathology.
Key Genes Involved in GO:0047316 L-glutamine:phenylpyruvate transaminase activity
The following genes and proteins are directly or functionally associated with L-glutamine:phenylpyruvate transaminase activity (GO:0047316) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KYAT1 (CCBL1) | Encodes glutamine transaminase K / kynurenine aminotransferase I; primary enzyme for GO:0047316 | Central to studying transamination, detoxification, and kynurenine metabolism [4,7] |
| KYAT3 (CCBL2) | Kynurenine aminotransferase III; may share overlapping substrate specificity | Potential compensatory enzyme in GTK knockout models |
| GOT1 | Cytosolic aspartate aminotransferase; related aminotransferase | Comparative studies of substrate specificity |
| GOT2 | Mitochondrial aspartate aminotransferase | Provides context for subcellular compartmentation of transamination |
| GPT | Alanine aminotransferase; uses pyruvate as amino acceptor | Model for understanding keto acid specificity |
| TAT | Tyrosine aminotransferase; can transaminate phenylpyruvate | Overlapping activity with GTK in phenylalanine metabolism |
| GLS | Glutaminase; produces glutamate from glutamine | Upstream of glutamine utilization; interacts with GTK pathways |
| GLUL | Glutamine synthetase; synthesizes glutamine | Balances glutamine pools used by GTK |
| IDO1 | Indoleamine 2,3-dioxygenase; initiates kynurenine pathway | Links to GTK-mediated kynurenic acid production |
| TDO2 | Tryptophan 2,3-dioxygenase; alternative kynurenine pathway initiator | Context for kynurenine availability |
| KMO | Kynurenine 3-monooxygenase; competes with GTK for kynurenine | Determines metabolic flux toward neurotoxic vs neuroprotective metabolites |
| AADAT | Kynurenine aminotransferase II; another kynurenic acid producer | Redundancy in kynurenic acid synthesis |
| SLC7A5 | L-type amino acid transporter; imports glutamine and phenylalanine | Affects substrate availability for GTK |
| SLC1A5 | Neutral amino acid transporter; glutamine uptake | Modulates intracellular glutamine for transamination |
| PLP (pyridoxal 5'-phosphate) | Essential cofactor for all aminotransferases | Required for GTK catalytic activity |
| PDXK | Pyridoxal kinase; generates PLP | Regulates cofactor supply for GTK |
| PNPO | Pyridoxamine 5'-phosphate oxidase; produces PLP | Alternative PLP source |
How Is L-glutamine:phenylpyruvate transaminase activity Regulated?
The activity of L-glutamine:phenylpyruvate transaminase is regulated at multiple levels. Substrate availability of glutamine and phenylpyruvate directly influences flux through the reaction. The enzyme requires pyridoxal 5'-phosphate (PLP) as a cofactor, so regulation of PLP synthesis and recycling can affect activity. Hormonal signals, such as glucocorticoids, may modulate expression of aminotransferases in liver and kidney, although specific data for GTK are limited. In the brain, kynurenine pathway flux, which competes with GTK for substrates, is influenced by inflammatory cytokines and metabolic state. Additionally, the dual substrate specificity of GTK means that the presence of alternative amino donors like cysteine S-conjugates can competitively inhibit glutamine-dependent transamination [4,8].
L-glutamine:phenylpyruvate transaminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KYAT1 (CCBL1) | Alzheimer's disease; kynurenine pathway imbalance | Knockout mice or human cell lines with KYAT1 KO to assess kynurenic acid levels |
| KYAT1 (CCBL1) | Toxicant-induced nephrotoxicity | Overexpression of KYAT1 in renal epithelial cells followed by exposure to cysteine S-conjugates |
| KYAT1 (CCBL1) | Metabolic acidosis; renal ammoniagenesis | Kidney-specific knockout or knockdown in rodent models |
| KYAT3 (CCBL2) | Neurological disorders; kynurenic acid synthesis | Double knockout with KYAT1 to study redundancy |
| TAT | Phenylketonuria; phenylalanine metabolism | Liver-specific overexpression or knockout to model phenylalanine clearance |
Alzheimer's Disease and Kynurenine Pathway Dysregulation
Alterations in kynurenine metabolism have been reported in Alzheimer's disease, where an imbalance between neuroprotective kynurenic acid and neurotoxic quinolinic acid may contribute to neurodegeneration. Because glutamine transaminase K (GTK) catalyzes the synthesis of kynurenic acid from kynurenine, changes in its activity could influence disease progression [5,7]. However, direct evidence linking GTK mutations to Alzheimer's disease is currently lacking, and further research is needed.
Kidney Ammoniagenesis and Metabolic Acidosis
In the kidney, phenylpyruvate-specific glutamine transaminase activity contributes to ammoniagenesis, the process by which the kidney excretes acid and generates ammonia. This activity is important for maintaining acid-base balance, and its dysregulation could potentially impact conditions such as metabolic acidosis. Studies in rat kidney have characterized this enzyme activity, but human data are limited.
Toxicant Bioactivation and Environmental Health
GTK can bioactivate cysteine S-conjugates of halogenated alkenes to reactive thiols that cause nephrotoxicity and neurotoxicity. This makes GO:0047316 relevant to toxicology and environmental health, as individuals with higher GTK activity might be more susceptible to certain chemical exposures. The enzyme's dual role in detoxification and bioactivation underscores the need for careful study [4,8].
From L-glutamine:phenylpyruvate transaminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic efficiency of GTK for glutamine vs. cysteine S-conjugates? | Purified recombinant enzyme with site-directed mutagenesis of active site residues |
| How does GTK loss affect kynurenic acid levels in the brain? | KYAT1 knockout mice or CRISPR KO in neuronal cell lines |
| Does GTK contribute to renal ammoniagenesis in vivo? | Kidney-specific KYAT1 knockout mice |
| Can GTK overexpression protect against toxicant exposure? | Knock-in or overexpression of KYAT1 in cell culture and animal models |
| What is the subcellular localization of GTK in different tissues? | Tagged knock-in of KYAT1 with fluorescent protein in cell lines |
| How do point mutations in KYAT1 affect substrate specificity? | CRISPR-mediated point mutation knock-in in isogenic cell lines |
How to Study the L-glutamine:phenylpyruvate transaminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric transaminase assay | Enzyme activity by NADH oxidation or colorimetric detection | Kinetic characterization of GTK from tissue lysates |
| LC-MS metabolomics | Levels of glutamine, phenylalanine, 2-oxoglutaramate, kynurenic acid | Assessing metabolic impact of GTK knockout |
| CRISPR-Cas9 knockout | Loss of gene function | Creating KYAT1 KO cell lines to study GO:0047316 |
| Site-directed mutagenesis | Effect of specific amino acid changes on catalysis | Mapping active site residues in GTK |
| Activity staining | In situ enzyme activity in tissue sections | Localizing GTK in kidney and brain |
| Western blot | Protein expression levels | Validating knockout or overexpression |
| qRT-PCR | mRNA expression | Measuring KYAT1 transcript levels |
| Fluorescence microscopy | Subcellular localization | Tracking tagged GTK in live cells |
Enzymatic Activity Assays
Direct measurement of L-glutamine:phenylpyruvate transaminase activity can be performed using spectrophotometric or fluorometric assays that monitor the formation of 2-oxoglutaramate or L-phenylalanine. These assays typically use purified enzyme or tissue homogenates and require PLP as a cofactor [1,4]. Such methods are essential for characterizing kinetic parameters and substrate specificity.
CRISPR-Cas9 Knockout and Knock-in Models
CRISPR-Cas9 technology enables the generation of KYAT1 knockout cell lines and animal models to study the loss of GO:0047316 activity. Knock-in of point mutations can reveal structure-function relationships, while tagged knock-in allows visualization of enzyme localization [3,6]. These models are invaluable for linking the activity to cellular phenotypes.
Metabolomics and Flux Analysis
Metabolomic profiling using mass spectrometry can quantify levels of glutamine, phenylalanine, 2-oxoglutaramate, and kynurenic acid in cells or tissues. Stable isotope tracing can track flux through the transamination reaction, providing insights into metabolic network rewiring upon GTK manipulation [4,5].
Histochemical Staining and Imaging
Activity staining of glutamine transaminase K and cysteine S-conjugate beta-lyase on tissue sections allows spatial mapping of enzyme activity. Immunofluorescence or fluorescent tagging can localize the enzyme within cells, revealing its cytosolic distribution and potential interactions with other proteins.
How CRISPR Can Be Used to Study GO:0047316 L-glutamine:phenylpyruvate transaminase activity
Knockout
CRISPR-Cas9 knockout of KYAT1 (CCBL1) eliminates L-glutamine:phenylpyruvate transaminase activity, allowing researchers to study its contribution to glutamine metabolism, kynurenic acid production, and detoxification. Knockout cell lines can be used in metabolic assays and toxicant sensitivity tests [4,5].
Point Mutation
Introducing specific point mutations in KYAT1 via CRISPR can dissect the roles of catalytic residues or substrate-binding sites. For example, mutating the PLP-binding lysine would abolish activity, while other mutations might alter substrate specificity.
Knock-in
Knock-in of a tagged version of KYAT1 (e.g., GFP or FLAG) enables visualization and immunoprecipitation of the enzyme in its native context. This approach helps determine subcellular localization and interaction partners.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of KYAT1 can increase GO:0047316 activity, useful for studying the effects of elevated transamination on cellular metabolism and resistance to toxicants.
How EDITGENE Supports L-glutamine:phenylpyruvate transaminase activity Research
Researchers studying L-glutamine:phenylpyruvate transaminase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways, disease phenotypes, or drug responses. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for L-glutamine:phenylpyruvate transaminase activity research.
Frequently Asked Questions About L-glutamine:phenylpyruvate transaminase activity
What is L-glutamine:phenylpyruvate transaminase activity?
It is a molecular function (GO:0047316) that catalyzes the transfer of an amino group from L-glutamine to 3-phenylpyruvate, producing 2-oxoglutaramate and L-phenylalanine. This activity is also known as glutamine transaminase K.
What genes are involved in L-glutamine:phenylpyruvate transaminase activity?
The primary gene is KYAT1 (also called CCBL1), which encodes glutamine transaminase K. Other related genes include KYAT3, TAT, and GOT1, which share overlapping substrate specificities [4,7].
What is the reaction catalyzed by GO:0047316?
The reaction is: 3-phenylpyruvate + L-glutamine = 2-oxoglutaramate + L-phenylalanine. It is a reversible transamination.
Which tissues express glutamine transaminase K?
High activity is found in kidney, liver, and brain, with lower levels in other tissues [1,2,4].
How is glutamine transaminase K related to kynurenine metabolism?
GTK can transaminate kynurenine to form kynurenic acid, a neuroactive metabolite. This links GO:0047316 to the kynurenine pathway and neurological disorders [5,7].
What diseases are associated with L-glutamine:phenylpyruvate transaminase activity?
Altered activity has been implicated in Alzheimer's disease, kidney ammoniagenesis disorders, and toxicant-induced nephrotoxicity [2,4,5].
What cofactor does glutamine transaminase K require?
It requires pyridoxal 5'-phosphate (PLP) as a cofactor for catalysis.
Can glutamine transaminase K use other substrates?
Yes, it can also use L-cysteine and cysteine S-conjugates as amino donors, linking it to sulfur metabolism and detoxification [4,8].
How can I study GO:0047316 in the lab?
Common methods include enzymatic activity assays, CRISPR knockout of KYAT1, metabolomics, and activity staining on tissue sections [1,4].
What CRISPR models are available for studying this activity?
Knockout, point mutation knock-in, tagged knock-in, and overexpression models can be generated for KYAT1 and related genes to dissect function [3,6].
Conclusion
L-glutamine:phenylpyruvate transaminase activity (GO:0047316) is a key enzymatic function in amino acid metabolism, with roles in glutamine utilization, phenylalanine synthesis, sulfur detoxification, and kynurenine pathway regulation. Its broad substrate specificity and tissue distribution make it relevant to kidney function, brain metabolism, and toxicology. Continued research using CRISPR-based models will further elucidate its contributions to health and disease.
References
- 1. Abraham DG et al.. 1991. Glutamine transaminase K and cysteine S-conjugate beta-lyase activity stains.. Anal Biochem 197(2):421-7 PMID: 1723851
- 2. Kopyt N et al.. 1986. Phenylpyruvate-specific glutamine transaminase and renal ammoniagenesis.. Miner Electrolyte Metab 12(5-6):347-51 PMID: 3807831
- 3. Bowsher RR et al.. 2020. Purification, characterization and identification of rat brain cytosolic tyrosine transaminase as glutamine Transaminase-K.. Neurochem Int 133:104653 PMID: 31874188
- 4. Cooper AJ. 2004. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants.. Neurochem Int 44(8):557-77 PMID: 15016471
- 5. Baran H et al.. 1999. Kynurenine metabolism in Alzheimer's disease.. J Neural Transm (Vienna) 106(2):165-81 PMID: 10226937
- 6. Hirotsu K et al.. 2005. Dual substrate recognition of aminotransferases.. Chem Rec 5(3):160-72 PMID: 15889412
- 7. Okuno E et al.. 1996. Kynurenine aminotransferases in the rat. Localization and characterization.. Adv Exp Med Biol 398:455-64 PMID: 8906305
- 8. Costa M et al.. 1986. Transamination of L-cystathionine and related compounds by a bovine liver enzyme. Possible identification with glutamine transaminase.. Biochim Biophys Acta 881(3):314-20 PMID: 3697372
